The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The market for pre-natal screening The global market for pre-natal testing is estimated at $4.2 billion. This market is undergoing rapid change as new technologies emerge which offer safer and better tests to allow pregnant women to determine their risk of having a fetus with Down's Syndrome or other genetic disorders. Pre-natal screening is already widely available throughout the developed world but existing tests are not completely accurate leading to many women with healthy pregnancies being incorrectly identified as "at risk" and subject to invasive follow up tests, which are stressful, costly and carry a risk to the fetus. Recent advances in DNA sequencing technology mean that it is now possible to perform a blood test which overcomes the problems with the existing tests by being more specific (>99 per cent. - means fewer false positives) more sensitive (>99 per cent. - higher detection rate) and is completely safe to the fetus. So compelling is the evidence surrounding this new approach the Directors and Proposed Directors believe that over time all pre-natal screening will be carried out this way. The Directors and the Proposed Directors believe that the market potential is significant. There are an estimated 9.5 million births per annum in the USA and Europe and an estimated 140 million births per annum globally. Initially the new tests will be primarily offered to the 20 per cent. of women at high risk of an affected fetus in the developed world with subsequent expansion to lower risk pregnancies and wider geographies. At present the price of the new DNA-based tests is between $800 and $1,800 suggesting a market size of between $4-8 billion in Europe and the USA alone. Over time the price will fall but the number of women taking the test will increase. A recent market report estimated the existing market potential as $1.5 billion growing to $5 billion in 2018 if a reliable cost effective test was available to encourage widespread adoption. It is precisely this market need that the IONA® Test aims to address.
Thanks, received.
Just PM'd ya.
Didn't get the offer but bought on open market today @ .158 so looking forward to the coming months and sales.....good elements to this one having done my research. GLA
Thanks Drif, yer WSG and VIY are my current and only plays in AIM at the minute.
c**p
It says in the paperwork that any shares not taken up will be split between whoever's left on a pro-rata basis, so we should get a few extra each, as some people inevitably won't buy for whatever reason maybe can't afford it or missed the deadline etc etc..
load up here guys, see this doing extremely well next week. calm before the storm. won't be many shares around. GLA
Only %45 in public hand,with a Market currently of around £4.3M,thats only £1.93M in private investors hands,that is not allot. On positive news there will be rush for shares which are in short supply. Considering this was over subscribed by over %300 that can mean only one thing,this is going up.
I suppose with your profits you could have a patio in your back garden. What this company is doing is a good thing which will help allot of couples.
i phoned my broker yesterday and they felt it would be oversubscribed and extra shares on top of the entitlement would be unlikely. I decide to just take my entitlement and leave the extras as i didnt want to bother with refund waits. very much worth buying at these prices given the news flow to come and the size of the market for this service. (£4.2 billion) i see a very big upside to come here.
got it thanks, future looks bright here.
Agreed, I also think as time goes on there will be further RNS on ii holdings as the weak pi sells the ii will buy, Reducing the amount available to the pi.
PMd ya mate.
Good post, 2 shares in AIM is plenty, I have 4 im overexposed but thats a risk im addressing, first im building here.
Gift horse, I have plenty of shares here thanks but I basically asked for a gift of 3 times more. Oliver twist stuff.
I didnt take up my OO. Felt exposed enough, and didnt feel comfortable with the dilution, and consolidation, these two have never gone well in my experience. But have some confidence in the new company so I've left my original holding in to so how it goes post consolidation. Will give it till xmas.
They where 3 times over subscribed,so no chance of getting extra shares. If you want more just buy on the open market.
Yep its better than 3 years of trials and dilution, but now its the hard part, sales required, and required all over Europe, so what part of 4 billion will VIY get exactly?
multibagger waiting to happen, directors will drive this to .5p per their options very quickly. Institutions loaded up. 55% shares not in public hands. anything around this SP is a giveaway imo.
I applied for a further 45000 as well as the 15000 im entitled to.
That was my trade,just bought in today,then they increase the spread,they are short of shares.
Big spread, move down to swallow up more shares. This will end over 16 today
do us a favour guys - can you let us know if you get any of the extra shares you asked for? When I spoke to VIY they implied that they couldnt imagine people being able to get the extras they asked for as they expected demand to be very high. Im curious to see if everyone took up their allowance. Cheers
thats not strictly accurate its not a drug for downs syndrome. its a non invasive test for pregnant women to establish if the foetus has downs.